In this study, through a kinome‐wide RNAi screen, we identified PANK4 as a synthetic lethal partner of TMZ in drug‐resistant GBM cells and demonstrated that its depletion enhances the effect of TMZ, improving the response to TMZ therapy. This evidence concerns the gene PANK4 and glioblastoma.